NCT07356557 Evaluation of Therapeutic Adherence Among Patients Followed in the Department of Hereditary Metabolic Diseases at Necker Hospital
| NCT ID | NCT07356557 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Metabolic Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-02-23 |
| Primary Completion | 2028-02-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2026-02-23 with a primary completion date of 2028-02-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate treatment adherence among patients followed in the Department of Inherited Metabolic Diseases at Necker Hospital, in order to assess the need for implementing a therapeutic education workshop focused on medication adherence.
Eligibility Criteria
Inclusion Criteria: * All patients followed in the Hereditary Metabolic Diseases department of Necker Hospital during their visit to the department for their usual care and having a specific daily oral medication treatment. * Children aged at least 7 years and adolescents/young adults * Holders of parental authority and children or adolescents or adults' patients informed and consenting to participate in the study Exclusion Criteria: * Metabolic disease without oral medication (intravenous treatments, amino acid mixtures, and dietary regimens are not evaluated). * Patient and parents not proficient in French. * Refusal by the patient's holders of parental authority or adult patient to participate in the study and/or refusal of the child/adolescent.
Contact & Investigator
Margaux MD GASCHIGNARD, M.D.
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT07356557 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 20 Years, studying Metabolic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07356557 currently recruiting?
Yes, NCT07356557 is actively recruiting participants. Contact the research team at margaux.gaschignard@aphp.fr for enrollment information.
Where is the NCT07356557 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT07356557 clinical trial?
NCT07356557 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Margaux MD GASCHIGNARD, M.D. at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 200 participants.